2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinoma
2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinoma
Speakers: Maria Jiang & Scott North
Objectives
By the end of this program, participants can expect to:
- Adapt to the evolving treatment landscape for mUC
- Understand the importance of multidisciplinary care in mUC
- Address challenges and shape future directions in mUC care
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
This program has received financial support from Merck & Pfizer in the form of an educational grant.